Cytosmart
Innovative solutions bringing laboratory precision to the forefront with devices like Lux2, Exact, and Omni, trusted by leading institutions worldwide.
Innovative solutions bringing laboratory precision to the forefront with devices like Lux2, Exact, and Omni, trusted by leading institutions worldwide.
Cytosmart is a Netherlands-based company that has been developing innovative laboratory devices since 2012. The company's product lineup includes Lux2, Exact, and Omni, which are trusted by leading institutions worldwide, such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews. In March 2019, Cytosmart secured a €5.20M Series B investment from BOM Brabant Ventures, Holland Capital, and Eindhoven Venture Capital Fund II.
The company's slogan, "Innovative solutions bringing laboratory precision to the forefront," reflects its commitment to pioneering technologies. Cytosmart's devices are designed to bring laboratory precision to the forefront, catering to both businesses and individual researchers. With a focus on Information Technology and Mobile industries, Cytosmart continues to make significant strides in the global market, solidifying its position as an industry leader in innovative laboratory solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | €5.20M | 3 |
|
25 Mar 2019 |
| Series A | €1.50M | 2 |
|
13 Jun 2016 |
No recent news or press coverage available for Cytosmart.
We care about your data, and we'd love to use cookies make your experience better.
